| http://www.w3.org/ns/prov#value | - The Fraunhofer Institute, a network or more than 60 research centers mainly based in Germany, with 30% of its funding from the German government and 70% from industry partners, gains from the deal by being able to exploit Sanofi???s collection for non-medical uses with its own partners.
|
